News

2021

Oct 29

Friday, October 29, 2021

Dechra acquires Sucromate™ Equine (deslorelin acetate) sterile suspension from Thorn Bioscience L.L.C

This acquisition expands Dechra’s equine portfolio in the reproductive category.

keyboard_arrow_right

Read more

2021

Oct 21

Thursday, October 21, 2021

Dechra receives approval for Amoxicillin and Clavulanate Potassium Oral Suspension Drops

Approval expands Dechra’s growing companion animal products (CAP) range of anti-infectives.

keyboard_arrow_right

Read more

2021

Oct 15

Friday, October 15, 2021

Dechra Acquires Rompun® (xylazine injection) 100mg/ml and Butorphanol Tartrate Injection 10mg/ml from Elanco™ Animal Health

Acquisition expands Dechra’s equine portfolio into the anesthesia and analgesia category.

keyboard_arrow_right

Read more

2021

Sep 28

Tuesday, September 28, 2021

Dechra Acquires Exclusive License from Hassinger Biomedical for Equine ProVet APC™

Dechra Veterinary Products is pleased to announce the acquisition of the veterinary marketing and distribution rights to the ProVet APC™ (Autologous Platelet Concentrate) and ProVet BMC™ (Bone Marrow Concentrate) systems from Hassinger Biomedical. These two patented medical devices concentrate platelets or bone marrow in 90 seconds with a processing time of 2.5 minutes from start to finish.

keyboard_arrow_right

Read more

2021

Mar 17

Wednesday, March 17, 2021

Dechra Veterinary Products Partners with I-MED Pharma

Dechra Veterinary Products is pleased to announce its exclusive marketing, sales, and distribution agreement with I-MED Pharma, the Canadian leader in dry eye management, for three innovative veterinary hyaluronic acid (HA) ophthalmic products.

keyboard_arrow_right

Read more

2020

Aug 05

Wednesday, August 5, 2020

Dechra Veterinary Products Announces their Sponsorship of the University of Pennsylvania Veterinary Working Dog Center Residency

keyboard_arrow_right

Read more

keyboard_arrow_up